BCDA
Biocardia IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.91M
P/E Ratio
—
EPS
$-1.23
Beta
0.55
52W High
$3.20
52W Low
$1.00
50-Day MA
$1.22
200-Day MA
$1.54
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Biocardia Inc
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.96M |
| EBITDA | $-8.25M |
| Operating Margin | 0.00% |
| Return on Equity | -950.00% |
| Return on Assets | -145.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.08 |
| Price-to-Book | 14.42 |
| Price-to-Sales (TTM) | 1985.81 |
| EV/Revenue | 3111.7 |
| EV/EBITDA | -3.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $10.94M |
| Float | $8.34M |
| % Insiders | 25.93% |
| % Institutions | 6.89% |
Data last updated: 4/7/2026